Growth Kinetics of Macronodular Lung Metastases and Survival in Differentiated Thyroid Carcinoma
Authors:
- 1 July 2017
- journal article
- research article
- Published by SAGE Publications in Thyroid®
- Vol. 27 (7) , 915-922
Abstract
Background: The clinical course of patients with lung metastases of differentiated thyroid carcinoma (DTC) vary, and cancer-specific survival (CSS) can be associated with tumor burden. This study evaluated the growth kinetics of lung metastases from DTC using serial chest computed tomography for Response Evaluation Criteria in Solid Tumors assessment and its prognostic implications. Methods: Forty-four patients with macronodular lung metastases (≥1 cm) of DTC were included. The time intervals to disease progression of lung metastases were measured and compared to CSS rates. Results: On the basis of the time to progression, 15 (34%), 17 (39%), and 12 (27%) patients were classified into the slow (≥3 years), moderate (1–3 years), and rapid groups (R 2 = 0.973, p = 0.013) in the rapid group, and the estimated doubling time of the tumor burden in the moderate and slow groups was 5.9 years and 19.3 years, respectively. No independent variable predicted the growth kinetics of lung metastases. In multivariate analysis, disease progression within the first year was an independent predictor of CSS (hazard ratio = 8.6; p = 0.003). Conclusions: This is the first study to demonstrate objectively that tumor growth kinetics within the first year are an independent predictor of CSS in patients with macronodular lung metastases. Performing chest computed tomography at least twice a year in the early phase of the disease in patients with macronodular lung metastases may be helpful for identifying high-risk patients who are eligible for treatment with tyrosine kinase inhibitors.Keywords
This publication has 21 references indexed in Scilit:
- 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid CancerThyroid®, 2016
- Pulmonary metastases in differentiated thyroid cancer: efficacy of radioiodine therapy and prognostic factorsEuropean Journal of Endocrinology, 2015
- Lung metastases from differentiated thyroid carcinoma: prognostic factors related to remission and disease‐free survivalClinical Endocrinology, 2014
- Long-Term Prognosis of Differentiated Thyroid Cancer with Lung Metastasis in Korea and Its Prognostic FactorsThyroid®, 2014
- Radioiodine Therapy in Differentiated Thyroid Cancer: The First Targeted Therapy in OncologyEndocrinology and Metabolism, 2014
- Current Status and Future Perspectives in Differentiated Thyroid CancerEndocrinology and Metabolism, 2014
- Prognostic Indicators of Outcomes in Patients with Distant Metastases from Differentiated Thyroid CarcinomaJournal of the American College of Surgeons, 2003
- A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985-1995Cancer, 1998
- Papillary and Follicular Thyroid CarcinomaNew England Journal of Medicine, 1998
- Long-Term Results of Treatment of 283 Patients with Lung and Bone Metastases from Differentiated Thyroid CarcinomaThe Journal of Clinical Endocrinology & Metabolism, 1986